Company Filing History:
Years Active: 2016
Title: Anna Kaskel: Innovator in T-Cell Expansion Technology
Introduction
Anna Kaskel is a prominent inventor based in Vaterstetten, Germany. She has made significant contributions to the field of immunology, particularly in the area of T-cell expansion. Her innovative work has the potential to advance research in various diseases and conditions.
Latest Patents
Anna Kaskel holds a patent for "Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool." This patent describes a system and methods for selectively inducing the expansion of T cells without the need for exogenous growth factors, such as lymphokines, and accessory cells. The cell-based expansion system allows for the long-term growth of cytotoxic T lymphocytes (CTLs), specifically human CTLs. Furthermore, T-cell proliferation can be induced without the requirement for antigen, resulting in a polyclonal T-cell population with respect to antigen reactivity. The methods outlined in her patent also facilitate the screening and identification of antigens related to specific diseases, tumors, autoimmune disorders, or infectious diseases, aiding in the development of targeted research and vaccines.
Career Highlights
Anna Kaskel is affiliated with the University of Pennsylvania, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to T-cell expansion, which is crucial for advancing immunotherapy and vaccine development.
Collaborations
Anna collaborates with esteemed colleagues, including Carl H. June and James L. Riley, who are also recognized for their contributions to the field of immunology. Their combined expertise enhances the impact of their research and fosters advancements in T-cell therapies.
Conclusion
Anna Kaskel's innovative work in T-cell expansion technology represents a significant advancement in immunological research. Her contributions have the potential to influence the development of therapies for various diseases and improve our understanding of immune responses.